Friday, October 2, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· May 20, 2026

Crypto News: Pepeto Crosses $10.13 Million While Bitcoin Price Prediction Targets $150,000 as Senate Votes to End Trump's Iran War

View original at globenewswire.com
“Over $10.13 million raised, stages closing in days, and addresses tied to large Bitcoin holders entering at a speed that says everything.”
Verbatim excerpt from the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Bitcoin trades at $77,070 on May 20, 2026

    60% confidence
  • Bitcoin price prediction for 2026 sits at $150,000

    60% confidence
  • Pepeto is the first presale to combine a zero-fee exchange, AI contract review, and staking returns as high as 172% APY

    60% confidence
  • Xi Jinping offered to help end the Iran conflict at the China summit

    60% confidence
  • Every trade on PepetoSwap generates buying pressure on the Pepeto token, the same model that lifted BNB from pennies to $1,369

    60% confidence
  • Bitcoin could reach $200,000 if Iran tensions end

    60% confidence
  • Crypto fund inflows hit $858 million last week, with Bitcoin products pulling $706 million and the largest weekly unwind of short positions in 2026

    60% confidence
  • Senate passed a war powers resolution 50-47 on May 19 with four Republicans joining Democrats to limit Trump's military operations in Iran

    60% confidence
  • On May 19, a tracked whale with $24.79 million in verified profits opened $21 million in longs across BTC, ETH, and DOGE

    60% confidence
  • Pepeto was built by the cofounder of the Pepe ecosystem, who created a $7 billion token, alongside a developer from Binance

    60% confidence

Data points we hold from this source

Pepeto · cash10.13 USD
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI-Driven Drug Development Meets Biotech Deal-Making and Regulatory Catalysts
AI-designed therapeutics (Insilico's rentosertib showing biological-age reductions) are moving into the clinical mainstream. Large-cap biotech is simultaneously reallocating capital through M&A (Lilly–Merida, $2.9B) and government funding (BARDA–Basilea), while trial failures (ziltivekimab, a 9.4% Novo Nordisk share drop) and upcoming FDA catalysts (the ivonescimab PDUFA on 2026-11-14) drive volatility. The wider AI regulatory and legal climate (Tesla Cybercab probe, xAI's Minnesota loss, OpenAI suits) is tightening, though QAIAx's micro-cap trial claims are speculative and weakly connected.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,327 source documents archived
Query this data → isubstrate.com